MAAT INDEX

CLAIM #43637 · Merck & Company Inc (MRK) · 2025Q4 earnings call · Feb 3, 2026 · due Dec 31, 2027

if you look at the $70 billion, we are going to derisk substantially all of that by the time we get to 2027.

Rob Davis · CEO

PENDING
graded after results covering Dec 31, 2027 are reported

How to check this claim

Look at: Amount of the $70 billion (patent exposure/revenue at risk) that has been derisked, as described by management (e.g., through new product approvals, life-cycle management, pipeline replacement)

It came true if: Management characterizes substantially all (approximately 90% or more) of the $70 billion as derisked by year-end 2027

Where: Management commentary on quarterly earnings calls through Q4 2027 / investor day disclosures

Verify independently

SEC filings for MRK · Claim quote is verbatim from the 2025Q4 earnings call.